CANADA LIFE ASSURANCE Co
InsurancePosition in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1046192
WINNIPEG, A2
Position in ARCT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$116,612
+$17,843 QoQ
Shares Held
17,353
+35.6% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 133 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. ARCT ranks #67 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in ARCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,612 | 17,353 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $98,769 | 12,794 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $73,615 | 12,009 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $134,022 | 7,272 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $74,222 | 5,705 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $57,863 | 5,464 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $92,978 | 5,479 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $140,420 | 6,050 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $130,248 | 5,349 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $151,694 | 4,492 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $128,137 | 4,064 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $112,547 | 4,405 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $73,994 | 2,580 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $64,215 | 2,679 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,988 | 2,063 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $26,913 | 1,816 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $25,955 | 1,649 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $39,442 | 1,463 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $48,594 | 1,313 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,807 | 1,168 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $39,525 | 1,168 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $48,238 | 1,168 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $50,667 | 1,168 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $50,107 | 1,168 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $54,592 | 1,168 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||